Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
      Description

      This is a randomized Phase II study of standard of care (SOC) chemotherapy monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast cancer.

      Conditions
      Metastatic Breast CancerTriple Negative Breast CancerEstrogen-receptor-low Breast Cancer
      Talk to us